Weight Management – Mounjaro

Mounjaro (Tirzepatide) access in Cheshire and Merseyside

Last updated: 17 June 2025

Access to Mounjaro (Tirzepatide) for weight loss

The new weight management medication ‘Tirzepatide’ (brand name Mounjaro®) is shortly being made available to NHS patients to support weight loss.

NHS Cheshire and Merseyside is currently in the process of establishing new community-based weight management services, which are set to launch this summer.  We’re working as quickly as possible to make these services available across Cheshire and Merseyside.

We’ll update this page and share information with local partners as soon as the new service is active, so please check back at regular intervals. Please don’t contact your GP before we confirm the new service is available in your area, as they won’t be able to refer you.

The drug is being made available on a phased basis, with the first group of people eligible under the national criteria being people who:

• Have a body mass index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds)

and

• Have at least four of the following long-term conditions:1.    Type 2 diabetes
  2.    Hypertension (high blood pressure)
  3.    Dyslipidaemia
  4.    Established cardiovascular disease
  5.    Obstructive sleep apnoea

Mounjaro (Tirzepatide) – NHS Cheshire and Merseyside